Overview
- Governments and patient groups staged orange-lighting events and public campaigns on May 29–30 to spotlight multiple sclerosis and press for concrete policy responses.
- In Mexico senators urged the Health Ministry to open talks and boost the budget for MS medicines after highlighting chronic shortages and the high monthly cost of some treatments reported at 80,000–90,000 pesos.
- Peruvian patient organizations said only 10–20% of the country’s estimated 3,000 people with MS get timely treatment, and Congress approved a draft to declare May 30 a national day to raise visibility.
- Argentine regional authorities and patient associations used the day to stress long diagnostic delays—regional studies show 20–50% waited two years or more—and the burden on families who must travel to capitals for neurologists and MRI scans.
- Medical experts reiterated that MS has no cure but early diagnosis and disease-modifying therapies can slow progression, which makes faster diagnosis, decentralised neurology services, and reliable drug supply central to reducing permanent neurological harm.